Melanoma

Reversing gp100/IFA-induced impairment of anti-CTLA-4 checkpoint blockade therapy
Yared Hailemichael, Tihui Fu, Hiep Khong, Zhimin Dai, Padmanee Sharma, Willem W Overwijk

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P14; DOI: 10.1186/2051-1426-2-S3-P14
Melanoma progression is associated with NK cell exhaustion
Ines Pires da Silva, Anne Gallois, Sonia Jimenez-Baranda, Ana Anderson, Vijay Kuchroo, Iman Osman, Nina Bhardwaj

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) O6; DOI: 10.1186/2051-1426-2-S3-O6
Immunoscore: a new possible approach for melanoma classification
Mariaelena Capone, Gabriele Madonna, Noemi Sebastiao, Jean Bird, Fabrizio Ayala, Corrado Caracò, Gennaro Ciliberto, Bonnie La Fleur, Nicola Mozzillo, Gerardo Botti, Alisa Tubbs, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P193; DOI: 10.1186/2051-1426-2-S3-P193
Patterns of long-term survival following Ipilimumab (Ipi): the Memorial Sloan Kettering Cancer Center 10-year metastatic melanoma (MM) experience
David B Page, Jarushka Naidoo, Parisa Momtaz, Kita Bogatch, Deborah Kuk, Katherine Panageas, Jianda Yuan, Jedd D Wolchok, Michael Postow

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P117; DOI: 10.1186/2051-1426-2-S3-P117
Dual-targeting nanoparticles for reprogrammed T cell responses in the tumor microenvironment
Alyssa K Kosmides, Jonathan Schneck

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P108; DOI: 10.1186/2051-1426-2-S3-P108
An image analysis algorithm based on the hue saturation density transformation, an important tool for melanoma immunotherapy research
Jeffrey A Dzubay, Alan Jerusalmi, Rajiv Jesudason, Johannes Zimmermann, Martin Baatz, Zipei Feng, Sachin Puri, Tarsem Moudgil, Carlo Bifulco, Bernard Fox

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P134; DOI: 10.1186/2051-1426-2-S3-P134
Defining the effects of age and gender on clinical immune response to cancer vaccination
Adriana Ramirez, Nolan Wages, Mark E Smolkin, Craig L Slingluff

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P59; DOI: 10.1186/2051-1426-2-S3-P59
Melanoma-derived Wnt5a conditions dendritic cells to promote regulatory T cell differentiation via the upregulation of indoleamine 2,3-dioxygenase: novel pharmacological strategies for augmenting immunotherapy efficacy
Fei Zhao, Kathy Evans, Alisha Holtzhausen, Ciriana Orabona, Brent A Hanks

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P209; DOI: 10.1186/2051-1426-2-S3-P209
CITN11-02 interim trial results: subcutaneous administration of recombinant human IL-15 (rhil-15) is associated with robust expansion of peripheral blood CD56+ NK cells
Chihiro Morishima, Douglas G McNeel, Manish R Patel, Holbrook Kohrt, Thomas A Waldmann, John A Thompson, Kevin Conlon, Paul M Sondel, Heather Wakelee, Mary L Disis, Stephen P Creekmore, Jeffrey S Miller

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P80; DOI: 10.1186/2051-1426-2-S3-P80
Mechanisms of TIGIT-driven immune suppression in cancer
Sema Kurtulus, Kaori Sakuishi, Huiyuan Zhang, Nicole Joller, Dewar Tan, Mark Smyth, Vijay Kuchroo, Ana Anderson

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) O13; DOI: 10.1186/2051-1426-2-S3-O13

Main menu

Melanoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Melanoma

Pages